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ABSTRACT 
The present era termed as age of Machines and Materialism has led to global 
economic advancement and affluence brought a drastic change in the life styles and 
living environment. Change in food habits, sedentary work, stressful environment etc. 
are the gifts of Industrialization to mankind. One side of life is happy with reduced 
physical activity and fat rich tasty food but the other side is showing affliction to 
chronic lifestyle disorders like diabetes mellitus, hypertension, cancer, ischemic heart 
disease, cerebro-vascular accidents, atherosclerosis, varicose veins etc. These diseases 
have been recognized as the leading killers of the millennium. Obesity is traced to be a 
major risk factor for these diseases. This study includes evaluate the applicability of 
concept of Visesha in Medoroga and clinical study on management of Medoroga by 
using Yavamalaka churna with special reference of “Prakopana viparyayo hi dhatunam 
prasham karanam iti”. Considering the above problem this study was planned the 
concept of “Prakopana viparyayo hi dhatunam prasham karanam iti” in the 
management of Medoroga with Yavamalaka churna because Medo dhatu is snigdha and 
guru in nature while Yava (Hordeum vulgarae) is Ruksha and Aguru and Amalaki 
(Emblica officinalis) also Ruksha in nature. The Amalaki has Tridoshahara properties 
especially Medohara. So these two drugs have opposite properties to medo dhatu. 
Hence due to the concept of Prakopana viparyayo hi dhatunam prashama karanam iti, 
yava and Amalaki cause the Hrasa of Medo dhatu.  
KEYWORDS: Medoroga, Sthoulya, Yavamalaka churna, Samanya, Visesha, Obesity. 
INTRODUCTION 
Obesity[1] is a contribution of the modern 
era. The emergence of this disease as a major 
health problem in public shows the epidemic 
form of the disease which is evident by rapid 
increase in its incidence. The world wide latest 
report on prevalence of obesity according to 
W.H.O. states that around 250 million cases of 
obesity are being reported every year afflicting 
about 7% of adult population. Total health care 
expenditure for obesity patients is estimated to 
be around 2-8% of total health cost. British 
Medical Journal states that two decades before 
1/3 of worldwide population were suffering 
from obesity. As per its report, obesity causes 
30,000 deaths per year. In spite of advanced 
technology and researches, the modern medicine 
is failing to give the best results for obesity, due 
to its multi-factorial nature. The importance of 
the adipose tissue in sustaining the body during 
starvation is evident even to a casual observer. 
Eating more energy than the body needs 
whether it is as fat, carbohydrate or protein 
leads to deposition of fat in the adipose tissue 
and contributes to development of obesity[2]. The 
causative factors are divided into three groups, 
Exogenous (Mostly related with over feeding), 
Endogenous (Related with endocrine factors), 
Miscellaneous (Remaining others are involved in 
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it). This failure made the people to look 
anxiously towards the ancient medical science 
like Ayurveda for better management. In 
Ayurveda, Medoroga[3] has been dealt by 
different Acharyas in reference to its causes, 
signs and symptoms[4], complications, prognosis 
and management. Acharya Charaka has 
described it as one among the Ashtanindita 
purusha[5] (eight despicable persons) and 
mentioned different principles of management. 
While Acharya Sushruta considers Sthoola [6] as 
sadatura because Sthoulya needs regular and 
continuous care and prevention is the best way 
of management. The principles of Samanya and 
Visesha[7-8] are very essential for the 
understanding of health and diseases. Due to the 
similar qualities of the substances our bodily 
tissues will causes growth. Similarly by regular 
intake of food which contains more fat causes 
Medovriddhi due to Samanya. In this conditions 
our Acharyas mentioned as “prakopana 
viparyayo hi dhatunam prasham karanam iti [9]”. 
It means we should select medicines Yava 
(Hordeum vulgare L.)[10] and Amalaki 
(Emblica officinalis Gaertn.)[11] which are having 
opposite qualities to  Medo dhatu. So, 
Yavamalaka churna is selected which is having 
Medohara properties and acting as Visesha to 
this disease. The present study was planned to 
evaluate the efficacy of Yavamalaka churna in 
the management of Medoroga considering its 
cost effectiveness and easy usage on regular 
basis. 
MATERIAL AND METHODS 
Step 1: preparation of Yavamalaka churna 
Materials 
 Yava (Hordeum vulgarae), Amalaki 
(Emblica officinalis) - 4:1 ratios. 
METHOD 
 Yava seeds cleaned, fried and then 
powdered in a grinder. Amalaki was powdered 
separately in grinder and mix the both powder. 
This is called Yavamalaka churna. 
Step 2: Clinical Study 
 30 patients were selected for this study 
from O.P.D. & I.P.D. of S. V. Ayurvedic College 
Hospital on the basis of inclusion and exclusion 
criteria. The selected patients were subjected to 
take the prescribed drugs, Bhrista yava powder 
mixed with hot water in the dose of 10 gm BD 
and Amalaki churna with honey 3 gm BD Orally 
with hot water in Prakbhaktam for a period of 3 
months. Treatment was planned under 
controlled diet pattern. All the patients were 
subjected to investigations as mentioned in 
material and methods. The progress and follow-
up study was conducted 30 days.  
Inclusion Criteria Age between 16-50 years, 
Waist hip circumference ratio >0.95 in males & 
>0.80 in females, BMI >25. 
Exclusion Criteria  
Patients aged below 16 yrs and above 50 
yrs, Patients with systemic, metabolic and 
endocrine disorders like Diabetes, 
Hypothyroidism etc. 
Assessment Criteria 
Efficacy of treatment was assessed by the 
marked changes observed in the signs and 
symptoms which were recorded before, during 
and after the course of clinical trial. The 
assessment was done with the help of objective 
parameters and self-graded assessment scale for 
subjective parameters.  
Subjective parameters 
Ayasa swasa (Dyspnoea on exertion), 
Adhika kshudha (Excessive Hunger), Athi Pipasa 
(excessive thirst), Sweda adhikyata (Excess 
sweating), Chalsphikudarastanah (Pendulous 
movement of hip, abdomen & breast), 
Daurgandhya (Bad body odours). 
Objective parameters: 
Weight, BMI, Circumference of Chest, Waist, Hip, 
& Mid-arm, Waist-Hip Ratio and Lipid profile. 
Grading for subjective parameters 
1. Assessment of Ayasa swasa (Dyspnoea on 
exertion):  
Absent - grade 0 
Dyspnoea on moderate work - grade 1 
Dyspnoea on slight work - grade 2 
Dyspnoea even at rest - grade 3 
2. Assessment of Adhika kshudha (excessive 
hunger) :  
Feels hunger at next annakala only - grade 
0 
Feels hunger for once in between Anna 
kala - grade 1 
Feels hunger for more than twice - grade 2  
Feels hunger always - grade 3 
3. Assessment of Athi Pipasa (excessive thirst): 
 Normal thirst - grade 0 
Up to one liter excess intake of water / 
fluids - grade 1 
Up to two-three liter excess intake of fluids 
- grade 2 
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More than three liter excess intake of fluids 
- grade 3 
4. Assessment of Sweda adhikyata (Excess 
sweating) :  
No sweating - grade 0 
Profuse sweating after moderate work - 
grade 1 
Profuse sweating after slight work - grade 
2 
Sweating even in resting condition - grade 
3  
5. Assessment of Chalsphikudarastanah 
(Pendulous movement of hip, abdomen & 
breast) :  
No feeling of movement - grade 0 
Feels slight movement but it doesn’t 
hampers routine work - grade 1 
Feels less movement and hampers routine 
work - grade 2 
Feels more movement - grade 3 
6. Assessment of Daurgandhya (Bad body 
odours) :  
Absent grade - 0 
Feeling after moderate work grade - 1 
Feeling after slight work - grade 2 
Feeling even in resting condition - grade 3 
OBSERVATION  
1. In the present study, 30 patients of 
Medoroga were treated with Yavamalaka 
churna. The effect of this therapy on the 
subjective and objective parameters of 
Medoroga patients are presented here. The 
mean score was reduced from 1.96 to 1.26 
with 35.59% of mean improvement with 
highly statically significant at the level of 
p<0.0001. 
Table 1: Changes in Ayasa swasa 
Response Changes Patients % 
No 0 11 36.7 
Mild 1 17 56.7 
Moderate 2 02 06.6 
Good 3 0 00 
2. The mean score was reduced from 2.20 to 
1.16 with 46.97% of mean improvement 
with highly statically significance at the level 
of p<0.0001. 
Table 2: Changes in pendulous movement of Sphik 
Response Changes Patients % 
No 0 4 13.3 
Mild 1 21 70 
Moderate 2 05 16.7 
Good 3 0 00 
3. The mean score was reduced from 2.36 to 
1.56 with 33.80% of mean improvement 
with highly statically significance at the level 
of p<0.0001. 
Table 3: Changes in pendulous movement of 
udara 
Response Changes Patients % 
No 0 11 36.7 
Mild 1 14 46.7 
Moderate 2 05 16.6 
Good 3 0 00 
4. The mean score was reduced from 1.93 to 
1.33 with 31.03% of mean improvement 
with highly statically significance at the level 
of p<0.0001. 
Table 4: Changes in pendulous movement of Stana 
Response Changes Patients % 
No 0 13 43.3 
Mild 1 16 53.4 
Moderate 2 01 3.3 
Good 3 0 00 
5. The mean score was reduced from 2.06 to 
1.10 with 46.77% of mean improvement 
with highly statically significance at the level 
of p<0.0001. 
Table 5: Changes in Ati kshudha 
Response Changes Patients % 
No 0 07 23.3 
Mild 1 17 56.7 
Moderate 2 06 20 
Good 3 0 00 
6. The mean score was reduced from 1.70 to 
1.03 with 39.21% of mean improvement 
with highly statically significant at the level 
of p<0.0001. 
Table 6: Changes in Ati pipasa 
Response Changes Patients % 
No 0 12 40 
Mild 1 16 53.3 
Moderate 2 02 6.7 
Good 3 0 00 
7. The mean score was reduced from 2.10 to 
1.03 with 50.79% of mean improvement 
with highly statically significant at the level 
of p<0.0001. 
Table 7: Changes in Swedadhikyata 
Response Changes  Patients % 
No 0 04 13.3 
Mild 1 20 66.7 
Moderate 2 06 20 
Good 3 0 00 
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8. The mean score was reduced from 2.03 to 
1.03 with 49.18% of mean improvement 
with highly statically significance at the level 
of p<0.0001. 
Table 8: Changes in Ati daurgandhyata 
Response Changes I                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Patients %
No 0 06 20 
Mild 1 18 60 
Moderate 2 06 20 
Good 3 0 00 
9. There was a maximum of 9 kg decrease, and 
it showed highest percentage i.e.26.7% of 
good response. The mean score was reduced 
from 82.96 to 78.03 with 36.91 of mean 
percentage benefit with highly statically 
significance at the level of p<0.0001. 
Table 9: Changes in weight before and after 
treatment 
Response Changes Patients % 
Poor 0-3 kg 09 30 
Moderate 3-6 kg 13 43.3 
Good 6-9 kg 08 26.7 
10. 50% percentage of patients showed good 
response i.e. >2 BMI variation, 33.3% 
showed 2and 16.7% showed ≤ 1 BMI 
variations. The mean score was reduced 
from 31.20 to 29.34 with 36.90 of mean 
improvement with highly statically 
significance at the level of p<0.0001. 
Table 10: Changes in BMI 
Response Changes Patients % 
Nil 0 0 0 
Mild ≤1 05 16.7 
Moderate 2 10 33.3 
Good >2 15 50 
11. 20% of patients showed a reduction of 
more than 2cm chest circumference, 63.3% 
showed 2cm, 10% showed ≤1cm. But only 
6.7% showed no response. The mean score 
was reduced from 95226 to 93.23 with 
25.93% of mean improvement with highly 
statically significance at the level of 
p<0.0001. 
Table 11: Changes in chest circumference 
Response Changes in  
cm. 
Patients % 
Nil 0 02 6.7 
Mild  1 03 10 
Moderate 2 19 63.3 
Good > 2 06 20 
12. 56.7% of the patients of showed the 
reduction of more than 2cm waist 
circumference. The mean score was reduced 
from 97 to 94.53 with 12.21% of mean 
improvement with highly statically 
significance at the level of p<0.0001. 
Table 12: Changes in waist circumference 
Response Changes in 
cm. 
Patients % 
Nil 0 00 00 
Mild  1 04 13.3 
Moderate 2 09 30 
Good > 2 17 56.7 
13. 30% of patients showed reduction of more 
than 2cm, 53.3% showed 2cm and 16.7% 
showed ≤1cm hip circumference. The mean 
score was reduced from 109.53 to 107.28 
with 15.60% of mean improvement with 
highly statically significance at the level of 
p<0.0001. 
Table 13: Changes in hip circumference 
Response Changes in 
cm. 
Patients % 
Nil 0 00 00 
Mild  1 05 16.7 
Moderate 2 16 53.3 
Good > 2 09 30 
14. There is no reduction more than 2cm of mid 
arm circumference. 
Table 14: Changes in mid arm circumference 
Response Changes  
in cm. 
Patients % 
Nil 0 07 23.3 
Mild  1 13 43.4 
Moderate 2 10 03.3 
Good > 2 0 0 
15. There is no reduction more than 1. 
Table 15: Changes in waist-hip ratio 
Response Changes Patients % 
Nil 0 08 26.6 
Mild  1 22 73.3 
Moderate 2 00 0 
Good > 2 00 0 
16. 46.7% patients showed mild reduction, 
26.7% patients showed moderate while 10% 
patients showed good response. 2 patients 
showed no response. 3 patients showed 
increase in serum cholesterol level. 
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Table 16: Changes in total serum cholesterol 
Response Changes in 
mg/dl 
Patients % 
Nil 0 2 6.6 
Mild 0-5 14 46.7 
Moderate 5-10 08 26.7 
Good > 10 03 10 
17. 43.3% of the patients showed a moderate 
increase, 20% showed good while 16.7% 
showed mild increase in serum HDL. But 6 
patients showed reduction in serum HDL 
level. 
Table 17: Changes in serum HDL 
Response Changes in  
mg/dl 
Patients % 
Mild 0-5 05 16.6 
Moderate 5-10 13 43.3 
Good > 10 06 20 
18. 56.6% patients showed moderate 
reduction, 23.3% showed mild and 6.6% 
showed good reduction in serum LDL level. 
But 4 patients showed increase in serum LDL 
level. 
Table 18: Changes in serum LDL 
Response Changes in  
mg/dl 
Patients % 
Mild 0-10 07 23.3 
Moderate 10-20 17 56.7 
Good > 20 02 06.6 
19. 63.3% of patient showed moderate 
reduction, 16.6% showed mild reduction and 
3.3% showed good reduction in serum 
triglyceride. But 5 patients showed increase 
in serum triglyceride level. 
Table 19: Changes in serum triglycerides 
Response Changes in  
mg/dl 
Patients % 
Mild ≤ 10 19 63.3 
Moderate 10-20 05 16.6 
Good ≥ 21 01 03.3 
 
















Ayasa shwasa  1.96 1.26 0.70 35.59 0.59 0.10 6.43 <0.001 HSS 
Chala sphik  2.20 1.16 1.03 46.97 0.55 0.10 1017 <0.001 HSS 
Chala stana  1.93 1.33 0.60 31.03 0.56 0.10 5.83 <0.001 HSS 
Chala udara 2.36 1.56 0.80 33.80 0.71 0.13 6.13 <0.001 HSS 
Ati Kshuda  2.06 1.10 0.96 46.77 0.66 0.12 7.91 <0.001 HSS 
Ati Pipasa  1.70 1.03 0.66 39.21 0.60 0.11 6.02 <0.001 HSS 
Swedhadhikya 2.10 1.03 1.06 50.79 0.58 0.10 10.01 <0.001 HSS 
Daurgandhya 2.03 1.03 1.00 49.18 0.64 0.11 8.51 <0.001 HSS 
















Weight  82.96 78.03 4.93 36.90 2.03 0.37 13.29 <0.001 HSS 
BMI 31.20 29.34 1.86 36.90 0.75 0.13 13.44 <0.001 HSS 
Chest Circum 95.26 93.23 2.03 25.93 0.97 0.17 11.44 <0.001 HSS 
Waist Circum 97.00 94.53 2.46 12.21 0.89 0.16 15.01 <0.001 HSS 
HipCircum 109.53 107.28 2.25 15.60 0.93 0.17 13.17 <0.001 HSS 
Mid Arm 
Circum 
31.03 30.11 0.91 29.23 0.68 0.12 7.34 <0.001 HSS 
Waist-Hip 
Ratio 




6.82 <0.001 HSS 
Total Serum 
Cholesterol 
157.4 152.57 4.83 76.56 6.41 1.17 4.12 <0.001 HSS 
Serum 
Triglyceride 
122.23 111.97 10.26 14.29 26.93 4.91 2.08 <0.046 SS 
Serum HDL 45.06 51.3 6.23 63.07 7.39 1.35 4.61 <0.001 HSS 
Serum LDL 91.66 80.8 10.86 11.70 10.82 1.97 5.50 <0.001 HSS 
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16.36 9.53 6.83 41.75 7.6 0.32 21.22 <0.001 HSS 
Total 
Parameters 
880.63 839.39 41.03 49.06 33.26 6.07 6.75 <0.001 HSS 
DISCUSSION 
Discussion on subjective parameters 
A total of eight subjective parameters 
were taken for the study. Most patients do not 
have significant complaints of subjective 
lakshanas. Because only patients with avara 
sthola were taken for the study as it was aimed 
at curative aspect. A few patients who 
complained of subjective Lakshanas have 
responded well in general. “Krucchra vyavaya” 
was not analyzed, as most of the patients were 
sensitive to reveal their sexual performance and 
their desire towards sex. Some of the 
parameters like Ayase shwasa, Chalatwa of 
Sphik, Udara and Sthana, Swedadhikyata, 
Daurgandhyata, Anga shitilatha responded 
mildly as the patients were mildly affected by 
these symptoms. This shows that yavamalaka 
churna is having significant efficacy in relieving 
associated features 
On weight: Patients had decreased weight with 
an average of 4.95  2.03 after completion of 
treatment. The maximum decrease was 9 kg. 
The t’ value of 13.29 (p<0.001) indicates that 
the patients has responded significantly 
towards the reduction of weight.  
On BMI: Maximum decrease of 3.07 with 
average decrease of 1.86  0.75 is seen after 
completion of treatment with ‘t’ value of 13.44 
which shows high significance (p<0.001).  
On lipid profile: Lipid profile was done for the 
subjects to assess the effect of drug on it. Lipid 
profile has shown response in reduction of 
triglycerides, LDL and total cholesterol, and an 
increase in HDL levels.  
Total Serum Cholesterol: All the patients had 
decrease in cholesterol level except in three 
subjects where there was increase. Out of 30 
patients 27 patients got decrease in their total 
cholesterol. Minimum decrease 0.00 mg/dl, 
Maximum decrease 19.00 mg/d. It has shown 
highly significant response of ‘t’ value of 4.12 
(p<0.001). The exact reason is not known for 
the increase in total cholesterol but the values 
taken before and after treatment were under 
normal limits and hence this change may be due 
to subjective physiological variation.  
HDL: The 24 patients had shown increase in 
HDL levels while 6 patients have shown 
decrease in HDL level. The minimum increase is 
2.00 mg/dl. The maximum increase is 20.00 
mg/dl. Out of 30 patients 6 patients had shown 
decrease in HDL levels. The reason for decrease 
in HDL of these patients is not known. The 
increase in HDL level i.e. good cholesterol 
indicating the efficacy of drugs.  
LDL: All patients had shown decrease in their 
LDL levels except 4 patients. The minimum 
decrease is 2.00 mg/dl. The maximum decrease 
is 23.00 mg/dl. There was decrease in LDL 
levels with an average of 10.86  10.82 mg/dl. 
Triglycerides: There was considerable 
variation in Triglycerides levels. All the patients 
had decrease in Triglycerides levels except 5 
patients. Minimum decrease 1.0 mg/dl, 
Maximum decrease 149.0 mg/dl, Average 
decrease 10.26  26.93 mg/dl 
Discussion on anthropometric (human body 
measurements) changes  
Reduction in body weight, B.M.I, 
Circumference, depends upon the proportion of 
fat. Fat is 1.5 times heavier than lean body mass 
and occupies more area in the body. So when 
the proportion of fat increases simultaneously 
body weight and body circumference also 
increases. When it reduces all these parameters 
also decrease. In the chapters of literary review 
it is already mentioned about the importance of 
anthropometric measurements. In brief, these 
measurements reflect the variation in the stored 
fat. And so the abdominal circumference, hip 
circumference and measurements of such other 
parts where fat is stored is helpful in assessing 
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the obesity. In the present study, there was 
decrease in various body measurements. The 
mean reduction in abdominal circumference is 
0.8 + 0.71 cm which is highly significant with p 
value of <0.001. There was similar reduction in 
the other anthropometric values as mentioned 
in the observation. Mild changes in these 
anthropometric values suggest that, the storage 
of fat under the skin was mildly decreased. 
CONCLUSION 
Medodhatu is snigdha and guru in nature 
while Yava is Ruksha and Aguru (Laghu) and 
Amalaki also Ruksha in nature especially 
Tridoshahara and Medohara. So these two 
Dravyas has opposite properties to Medo dhatu. 
Hence due to the concept of Prakopana 
viparyayo hi dhatunam prashama karanam iti, 
yava and Amalaki cause the Hrasa of Medo 
dhatu. The Aushadha kala as mentioned in the 
classics was advocated to treat the disease 
effectively because it causes Lekhan and 
Krishkarana. The diet and exercises are vital in 
maintaining Madhyama sharira and hence it 
constitutes part and parcel of obese individuals. 
These act as supportive therapy in the 
management of Medoroga. Internal usage of 
Yavamalaka churna has given significant results 
in reducing Medoroga. It is evident by the 
significant changes in the subjective and 
objective parameters documented before and 
after the treatment. 
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